Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study.

Comparison of idrabiotaparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: the Borealis-Atrial Fibrillation Study. J Thromb Haemost. 2014 Jun; 12(6):824-30.

View in: PubMed

subject areas

Administration, Oral
Administration, Oral
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Anticoagulants
Anticoagulants
Atrial Fibrillation
Atrial Fibrillation
Biotin
Biotin
Double-Blind Method
Double-Blind Method
Drug Administration Schedule
Drug Administration Schedule
Early Termination of Clinical Trials
Early Termination of Clinical Trials
Electrocardiography
Electrocardiography
Factor Xa Inhibitors
Factor Xa Inhibitors
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Injections, Subcutaneous
Injections, Subcutaneous
Male
Male
Middle Aged
Middle Aged
Oligosaccharides
Oligosaccharides
Predictive Value of Tests
Predictive Value of Tests
Risk Factors
Risk Factors
Stroke
Stroke
Thromboembolism
Thromboembolism
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Vitamin K
Vitamin K
Warfarin
Warfarin

authors with profiles

Gary E Raskob